IP Library Granted Patent US 7,914,982
Granted Patent B2
US 7,914,982 · App. 11/351,799 · Granted Mar 29, 2011

Methods for detecting pathogen specific nucleic acids in urine

Assignee: Trovagene, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,914,982
App. No.
11/351,799
Granted
Mar 29, 2011
Kind
B2
Abstract

The invention is based upon the discovery that small nucleic acids from non-viral pathogens are able to cross the kidney and are present in urine of a subject when the subject is infected with the non-viral pathogen. These transrenal DNAs are especially prevalent at smaller sizes under about 300 bp. Thus the invention provides compositions and methods for the diagnosis of infection of a subject with non-viral pathogens through the detection of transrenal nucleic acids from those pathogens in the urine of the subject.

Claims (7)

1. A method for diagnosing a Mycobacterium tuberculosis infection in a subject, comprising:

a) obtaining a urine sample from a subject;

b) separating a soluble fraction of said urine sample; and

c) detecting the presence of a cell-free Mycobacterium tuberculosis nucleic acid in said soluble fraction of said urine sample, wherein said nucleic acid is less than about 300 bp in length, wherein said detecting is performed by a method selected from the group consisting of PCR, nested PCR, semi-nested PCR, LCR, and SDA, using a primer set comprising at least one forward primer selected from the group consisting of SEQ ID NOs: 34, 37 and 39, and at least one reverse primer selected from the group consisting of SEQ ID NOs: 35, 36, 38 and 40, wherein the presence of said nucleic acid diagnoses a Mycobacterium tuberculosis infection.

2. The method of claim 1 , further comprising the step of quantitating the nucleic acid.

3. The method of claim 1 , wherein the subject is a mammal.

4. The method of claim 3 , wherein the mammal is a human.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2010
From: NATIONAL INSTITUTE OF INFECTIOUS DISEASES LAZZARO SPALLANZANI
To: XENOMICS, INC.
Reel/Frame 024809/0001 →
MERGER Recorded Aug 9, 2010
From: XENOMICS, INC.
To: TROVAGENE, INC.
Reel/Frame 024809/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2006
From: MELKONYAN, HOVSEP; UMANSKY, SAMUIL R.; CANNAS, ANGELA; TOMEI, LOUIS DAVID
To: INSTITUTO NAZINALE PER LE MALATTIE INFETTIVE IRCCS LAZZARO SPALLANZANI
Reel/Frame 017885/0740 →
Priority Claims (1)
IT RM2005A0068 · Feb 17, 2005 · national
Continuity (3)
Continuation In Part 11137934 · May 25, 2005
Provisional Application 60691186 · Jun 16, 2005
Related Publication 20070037181A1 · Feb 15, 2007